Bulletin 2010/15 - European Patent Office
22.12.2012 • Views
Share Embed Flag

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) II.1(1)<br />

A61K 38/39 → (51) C07K 14/78<br />

A61K 38/40 → (51) A61K 31/40<br />

(51) A61K 38/44 (11) 1 454 633 B1<br />

A61K 31/7084 A61P 17/14<br />

(25) En (26) En<br />

(21) 04425028.0 (22) 20.01.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 08.09.2004<br />

(30) 28.02.2003 IT MI20030369<br />

(54) • Topisch applizierbare kosmetische oder<br />

pharmazeutische Zusammensetzung zur<br />

Prävention oder Behandlung androgener<br />

Alopezie<br />

• Cosmetic or pharmaceutical composition<br />

for topical use to prevent or treat androgenetic<br />

alopecia<br />

• Composition cosmétique ou pharmaceutique<br />

topique pour la prévention ou le<br />

traitement de l'alopecie androgène<br />

(73) FARMAKA S.r.l., Via Vetreria, 1, 22070<br />

Grandate (Como), IT<br />

(72) Citernesi, Ugo Raffaello, 20040 Usmate<br />

Velate Milano, IT<br />

(74) Pizzoli, Pasquale Vincenzo, et al, Società<br />

Italiana Brevetti S.p.A, Via G. Carducci 8,<br />

20123 Milano (MI), IT<br />

A61K 38/46 → (51) C12P 21/08<br />

A61K 38/57 → (51) A61K 38/20<br />

(51) A61K 39/00 (11) 1 221 969 B1<br />

A61K 35/14 C12N 5/071<br />

A61P 35/00 A61P 31/00<br />

A61P 37/00<br />

(25) En (26) En<br />

(21) 00969488.6 (22) 11.10.2000<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

(43) 17.07.2002<br />

(86) EP 2000/010019 11.10.2000<br />

(87) WO 2001/026680 2001/16 19.04.2001<br />

(30) 13.10.1999 EP 99119980<br />

(54) • AKTIVIERUNG ANTIGEN-SPEZIFISCHER T-<br />

ZELLEN MIT VIRUS/ANTIGEN-BEHANDEL-<br />

TEN DENDRITISCHEN ZELLEN<br />

• ACTIVATION OF ANTIGEN-SPECIFIC T<br />

CELLS BY VIRUS/ANTIGEN-TREATED<br />

DENDRITIC CELLS<br />

• ACTIVATION DE CELLULES T A SPECIFI-<br />

CITE ANTIGENIQUE PAR DES CELLULES<br />

DENDRITIQUES TRAITEES AVEC UN<br />

VIRUS/ANTIGENE<br />

(73) Ahlert, Thorsten Dr., 2 Orchard Heights,<br />

Scarborough, YO12 6EH North Yorkshire, GB<br />

(72) Ahlert, Thorsten Dr., Scarborough, YO12<br />

6EH North Yorkshire, GB<br />

(74) Müller-Boré & Partner <strong>Patent</strong>anwälte, Grafinger<br />

Strasse 2, 81671 München, DE<br />

A61K 39/00 → (51) C07K 14/11<br />

A61K 39/00 → (51) C12N <strong>15</strong>/12<br />

(51) A61K 39/04 (11) 1 369 127 B1<br />

A61K 31/711 A61P 37/08<br />

A61P 27/00 A61P 11/06<br />

A61P 27/16<br />

(25) Ja (26) En<br />

(21) 02700618.8 (22) 20.02.2002<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 10.12.2003<br />

(86) JP 2002/001459 20.02.2002<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(87) WO 2002/066055 2002/35 29.08.2002<br />

(30) 20.02.2001 JP 2001043291<br />

(54) • NEUE MEDIZINISCHE VERWENDUNG VON<br />

ALPHA-ANTIGEN ODER ALPHA-ANTIGEN-<br />

GEN<br />

• NOVEL MEDICINAL USE OF ALPHA ANTI-<br />

GEN OR ALPHA ANTIGEN GENE<br />

• NOUVELLE UTILISATION EN MEDECINE<br />

D'UN ANTIGENE ALPHA OU D'UN GENE<br />

D'ANTIGENE ALPHA<br />

(73) MARUHO Co., Ltd., 5-22, Nakatsu 1-chome,<br />

Kita-ku, Osaka-shi, Osaka 531-0071, JP<br />

(72) YASUTOMI, Yasuhiro, Tsu-shi, Mie 514-<br />

0062, JP<br />

MIZUTANI, Hitoshi, Tsu-shi, Mie 514-0046,<br />

JP<br />

(74) Keen, Celia Mary, J.A. Kemp & Co. 14 South<br />

Square Gray's Inn, London WC1R 5JJ, GB<br />

A61K 39/095 → (51) A61K 39/39<br />

A61K 39/145 → (51) C07K 14/11<br />

(51) A61K 39/39 (11) 1 748 791 B1<br />

A61K 39/095 C07H 3/06<br />

A61P 31/00<br />

(25) En (26) En<br />

(21) 05745670.9 (22) 11.05.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

AL BA HR LV MK YU<br />

(43) 07.02.2007<br />

(86) NL 2005/000358 11.05.2005<br />

(87) WO 2005/107798 2005/46 17.11.2005<br />

(30) 11.05.2004 EP 04076401<br />

(54) • NEISSERIA MENINGITIDIS IgtB LOS ALS<br />

ADJUVANS<br />

• NEISSERIA MENINGITIDIS IgtB LOS AS<br />

ADJUVANT<br />

• LOS DE NEISSERIA MENINGITIDIS IgtB<br />

UTILISES EN TANT QU'ADJUVANTS<br />

(73) De Staat der Nederlanden, vert. door de<br />

minister van VWS, P.O. Box 20350, 2500 EJ<br />

The Hague, NL<br />

(72) STEEGHS, Liana, Juliana, Josephine, NL-<br />

3544 PP Utrecht, NL<br />

VAN DE WINKEL, Johannes, Gerardus,<br />

Joseph, NL-3707 CK Zeist, NL<br />

VAN DER LEY, Peter, André, NL-3572 DJ<br />

Utrecht, NL<br />

(74) Swinkels, Bart Willem, Nederlandsch<br />

Octrooibureau P.O. Box 29720, 2502 LS Den<br />

Haag, NL<br />

(51) A61K 39/395 (11) 0 831 903 B1<br />

A61K 38/18 C07H 21/04<br />

C07K 16/22 C07K 14/475<br />

(25) En (26) En<br />

(21) 96916841.8 (22) 31.05.1996<br />

(84) AT BE CH DE DK ES FI FR GB GR IE IT LI LU<br />

MC NL PT SE<br />

(43) 01.04.1998<br />

(86) US 1996/008140 31.05.1996<br />

(87) WO 1996/038172 1996/53 05.12.1996<br />

(30) 02.06.1995 US 459717<br />

(54) • BINDEGEWEBS WACHSTUMSFAKTOR<br />

(CTGF)<br />

• CONNECTIVE TISSUE GROWTH FACTOR<br />

• FACTEUR DE CROISSANCE DES TISSUS<br />

CONJONCTIFS<br />

(73) UNIVERSITY OF SOUTH FLORIDA, 4202 East<br />

Fowler Avenue, Tampa, FL 33620, US<br />

(72) GROTENDORST, Gary, R., Miami, FL 33176,<br />

US<br />

BRADHAM, Douglass, M., Jr., Sunnyvale,<br />

California 94086, US<br />

533<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>15</strong>/<strong>2010</strong>) 14.04.<strong>2010</strong><br />

(74) Jaenichen, Hans-Rainer, Vossius & Partner<br />

Postfach 86 07 67, 81634 München, DE<br />

(51) A61K 39/395 (11) 1 409 016 B1<br />

G01N 33/53 C07K 16/28<br />

A61P 19/08<br />

(25) En (26) En<br />

(21) 02749660.3 (22) 25.06.2002<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 21.04.2004<br />

(86) US 2002/020181 25.06.2002<br />

(87) WO 2003/002713 2003/02 09.01.2003<br />

(30) 26.06.2001 US 301172 P<br />

(54) • ANTIKÖRPER GEGEN OPGL<br />

• ANTIBODIES TO OPGL<br />

• ANTICORPS OPGL<br />

(73) Amgen Fremont Inc., 6701 Kaiser Drive,<br />

Fremont, CA 94555, US<br />

Amgen, Inc., One Amgen Center Drive Mailstop<br />

27-4-A, Thousands Oaks, CA 91320-<br />

1789, US<br />

(72) BOYLE, William, J., Malibu, CA 90265, US<br />

MARTIN, Francis, H., Newbury Park, CA<br />

91320, US<br />

CORVALAN, Jose, R., Foster City, CA 94404,<br />

US<br />

DAVIS, Geoffrey, C., Burlingame, CA 94010,<br />

US<br />

(74) Gowshall, Jonathan Vallance, et al, Forrester<br />

& Boehmert Pettenkoferstrasse 20-22,<br />

80336 München, DE<br />

(60) 09<strong>15</strong>6995.4 / 2 087 908<br />

A61K 39/395 → (51) C07K 16/28<br />

A61K 39/395 → (51) C12N <strong>15</strong>/12<br />

A61K 39/395 → (51) C12N <strong>15</strong>/13<br />

A61K 39/395 → (51) C12P 21/08<br />

A61K 45/00 → (51) C12N <strong>15</strong>/00<br />

A61K 45/00 → (51) C12N <strong>15</strong>/12<br />

A61K 45/00 → (51) G01N 33/53<br />

A61K 47/18 → (51) A61K 38/20<br />

(51) A61K 47/48 (11) 1 458 414 B1<br />

A61P 35/00<br />

(25) De (26) De<br />

(21) 02804919.5 (22) 19.12.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SI SK TR<br />

(43) 22.09.2004<br />

(86) EP 2002/014590 19.12.2002<br />

(87) WO 2003/051399 2003/26 26.06.2003<br />

(30) 19.12.2001 DE 10162521<br />

(54) • VERWENDUNG VON AN POLYALKY-<br />

LENGLYCOL GEKOPPELTEN THROMBI-<br />

NINHIBITOREN IN DER<br />

TUMORTHERAPHIE<br />

• USE OF THROMBIN INHIBITORS COUPLED<br />

TO POLYALKYLENE GLYCOL IN TUMOUR<br />

THERAPY<br />

• UTILISATION DE INHIBITEURS DE LA<br />

THROMBINE COUPLES A DU POLYALKY-<br />

LENE GLYCOL DANS LA THERAPIE DES<br />

TUMEURS<br />

(73) Nowak, Götz, Kirchhoffweg 7, 99097 Erfurt,<br />

DE<br />

(72) NOWAK, Götz, 99097 Erfurt, DE<br />

LOPEZ ZAMBRANO, Mercedes, 07747 Jena,<br />

DE<br />

(74) Vossius & Partner, Siebertstraße 4, 81675<br />

München, DE

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!